Related Experiment Video
Updated: Jun 28, 2026
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Developments in the scientific understanding of lupus
Stacy P Ardoin1, David S Pisetsky
1Department of Pediatrics, Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA. stacy.ardoin@duke.edu
Arthritis Research & Therapy
|October 25, 2008
Summary
Systemic lupus erythematosus (SLE) susceptibility involves genetic factors and impaired clearance of dead cells, promoting autoimmune responses. New therapies may target these genetic and immune markers for SLE treatment.
Area of Science:
- Immunology
- Genetics
- Autoimmune Diseases
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disorder marked by antinuclear antibody (ANA) production.
- Disease susceptibility is linked to genetic variations affecting immune regulation and apoptotic cell clearance.
- Accumulation of cellular debris can trigger immune responses, including ANA formation.
Purpose of the Study:
- To explore the genetic and immunologic factors contributing to systemic lupus erythematosus susceptibility.
- To identify potential new therapeutic targets for SLE based on disease mechanisms.
Main Methods:
- Review of recent research on human and murine lupus models.
- Analysis of genetic polymorphisms influencing immune responses.
- Investigation of the role of apoptotic cell clearance in disease pathogenesis.
Main Results:
- Genetic polymorphisms impairing immune responses and apoptotic cell clearance contribute to SLE susceptibility.
- Immunologic activity of dead cell products, like nucleic acids, promotes antigen-driven ANA responses.
- ANA-containing immune complexes induce cytokine production and the 'interferon signature,' worsening disease.
Conclusions:
- Findings highlight novel genetic and immunologic markers for SLE diagnosis and prognosis.
- Identified mechanisms provide potential targets for developing new SLE therapies.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:15Development of the Lymphatic System
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...